Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical pr...
Gespeichert in:
Veröffentlicht in: | Human reproduction update 2012-09, Vol.18 (5), p.474-484 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 484 |
---|---|
container_issue | 5 |
container_start_page | 474 |
container_title | Human reproduction update |
container_volume | 18 |
creator | Clark, Christine A Laskin, Carl A Spitzer, Karen A |
description | In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses. |
doi_str_mv | 10.1093/humupd/dms020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1030349006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1030349006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEYjA4ckU5cilzkjZtuE0TX9IkLnClSlMXgvq1pJ3Uf0-mDk5-LT-y7IeQGwb3DJRYfY_N2JersvHA4YRcsFhCxIVUpyGLJIniNJMLcun9DwCTLEvPyYJzqRQwuCCf63awRrvSdrXtbUt16IuutOhDLKlDMzqH7UBRu3qivcOvVrdmonXn_QPV1ITh6CbaVRR3o913RtcU97bE1uAVOat07fH6WJfk4-nxffMSbd-eXzfrbWSE4EOUKJmVRlaKZRlTuqhSlsaSMSkYxLzKtFRSa6MgKeBwOy8ApahSw1OeQYpiSe7mvb3rdiP6IW-sN1jXusVu9DkDASJWADKg0YwaFz5wWOW9s412U4Dyg9J8VprPSgN_e1w9Fg2W__SfQ_ELcDd0Zg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1030349006</pqid></control><display><type>article</type><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</creator><creatorcontrib>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</creatorcontrib><description>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</description><identifier>ISSN: 1355-4786</identifier><identifier>EISSN: 1460-2369</identifier><identifier>DOI: 10.1093/humupd/dms020</identifier><identifier>PMID: 22699010</identifier><language>eng</language><publisher>England</publisher><subject>Antibodies, Anticardiolipin - blood ; Antibodies, Anticardiolipin - immunology ; Antiphospholipid Syndrome - blood ; Antiphospholipid Syndrome - classification ; Antiphospholipid Syndrome - diagnosis ; Embryo Loss - blood ; Embryo Loss - immunology ; Female ; Humans ; Pregnancy ; Recurrence</subject><ispartof>Human reproduction update, 2012-09, Vol.18 (5), p.474-484</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</citedby><cites>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22699010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clark, Christine A</creatorcontrib><creatorcontrib>Laskin, Carl A</creatorcontrib><creatorcontrib>Spitzer, Karen A</creatorcontrib><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><title>Human reproduction update</title><addtitle>Hum Reprod Update</addtitle><description>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</description><subject>Antibodies, Anticardiolipin - blood</subject><subject>Antibodies, Anticardiolipin - immunology</subject><subject>Antiphospholipid Syndrome - blood</subject><subject>Antiphospholipid Syndrome - classification</subject><subject>Antiphospholipid Syndrome - diagnosis</subject><subject>Embryo Loss - blood</subject><subject>Embryo Loss - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Pregnancy</subject><subject>Recurrence</subject><issn>1355-4786</issn><issn>1460-2369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1PwzAMhiMEYjA4ckU5cilzkjZtuE0TX9IkLnClSlMXgvq1pJ3Uf0-mDk5-LT-y7IeQGwb3DJRYfY_N2JersvHA4YRcsFhCxIVUpyGLJIniNJMLcun9DwCTLEvPyYJzqRQwuCCf63awRrvSdrXtbUt16IuutOhDLKlDMzqH7UBRu3qivcOvVrdmonXn_QPV1ITh6CbaVRR3o913RtcU97bE1uAVOat07fH6WJfk4-nxffMSbd-eXzfrbWSE4EOUKJmVRlaKZRlTuqhSlsaSMSkYxLzKtFRSa6MgKeBwOy8ApahSw1OeQYpiSe7mvb3rdiP6IW-sN1jXusVu9DkDASJWADKg0YwaFz5wWOW9s412U4Dyg9J8VprPSgN_e1w9Fg2W__SfQ_ELcDd0Zg</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>Clark, Christine A</creator><creator>Laskin, Carl A</creator><creator>Spitzer, Karen A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><author>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Anticardiolipin - blood</topic><topic>Antibodies, Anticardiolipin - immunology</topic><topic>Antiphospholipid Syndrome - blood</topic><topic>Antiphospholipid Syndrome - classification</topic><topic>Antiphospholipid Syndrome - diagnosis</topic><topic>Embryo Loss - blood</topic><topic>Embryo Loss - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Pregnancy</topic><topic>Recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clark, Christine A</creatorcontrib><creatorcontrib>Laskin, Carl A</creatorcontrib><creatorcontrib>Spitzer, Karen A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction update</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clark, Christine A</au><au>Laskin, Carl A</au><au>Spitzer, Karen A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</atitle><jtitle>Human reproduction update</jtitle><addtitle>Hum Reprod Update</addtitle><date>2012-09</date><risdate>2012</risdate><volume>18</volume><issue>5</issue><spage>474</spage><epage>484</epage><pages>474-484</pages><issn>1355-4786</issn><eissn>1460-2369</eissn><abstract>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</abstract><cop>England</cop><pmid>22699010</pmid><doi>10.1093/humupd/dms020</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-4786 |
ispartof | Human reproduction update, 2012-09, Vol.18 (5), p.474-484 |
issn | 1355-4786 1460-2369 |
language | eng |
recordid | cdi_proquest_miscellaneous_1030349006 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Antibodies, Anticardiolipin - blood Antibodies, Anticardiolipin - immunology Antiphospholipid Syndrome - blood Antiphospholipid Syndrome - classification Antiphospholipid Syndrome - diagnosis Embryo Loss - blood Embryo Loss - immunology Female Humans Pregnancy Recurrence |
title | Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A21%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticardiolipin%20antibodies%20and%20recurrent%20early%20pregnancy%20loss:%20a%20century%20of%20equivocal%20evidence&rft.jtitle=Human%20reproduction%20update&rft.au=Clark,%20Christine%20A&rft.date=2012-09&rft.volume=18&rft.issue=5&rft.spage=474&rft.epage=484&rft.pages=474-484&rft.issn=1355-4786&rft.eissn=1460-2369&rft_id=info:doi/10.1093/humupd/dms020&rft_dat=%3Cproquest_cross%3E1030349006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1030349006&rft_id=info:pmid/22699010&rfr_iscdi=true |